Sompo Japan Nipponkoa Asset Management CO. LTD. bought a new position in Walgreens Boots Alliance Inc (NASDAQ:WBA) in the 3rd quarter, Holdings Channel reports. The institutional investor bought 113,790 shares of the pharmacy operator’s stock, valued at approximately $8,787,000.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Stifel Financial Corp grew its stake in shares of Walgreens Boots Alliance by 18.5% during the 3rd quarter. Stifel Financial Corp now owns 901,590 shares of the pharmacy operator’s stock valued at $69,470,000 after buying an additional 140,465 shares during the period. Pinebridge Investments L.P. grew its stake in shares of Walgreens Boots Alliance by 692.4% during the 3rd quarter. Pinebridge Investments L.P. now owns 174,636 shares of the pharmacy operator’s stock valued at $13,485,000 after buying an additional 152,596 shares during the period. Tredje AP fonden grew its stake in shares of Walgreens Boots Alliance by 50.8% during the 3rd quarter. Tredje AP fonden now owns 148,581 shares of the pharmacy operator’s stock valued at $11,473,000 after buying an additional 50,080 shares during the period. Commerzbank Aktiengesellschaft FI grew its stake in shares of Walgreens Boots Alliance by 109.5% during the 3rd quarter. Commerzbank Aktiengesellschaft FI now owns 17,857 shares of the pharmacy operator’s stock valued at $1,379,000 after buying an additional 9,332 shares during the period. Finally, Welch & Forbes LLC grew its stake in shares of Walgreens Boots Alliance by 2.8% during the 3rd quarter. Welch & Forbes LLC now owns 98,758 shares of the pharmacy operator’s stock valued at $7,626,000 after buying an additional 2,682 shares during the period. 61.18% of the stock is owned by hedge funds and other institutional investors.

In other news, Director John Anthony Lederer acquired 20,000 shares of the business’s stock in a transaction on Thursday, October 26th. The shares were purchased at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the acquisition, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the transaction, the director now owns 16,415 shares in the company, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Insiders own 14.80% of the company’s stock.

Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $72.92 on Monday. The company has a current ratio of 0.96, a quick ratio of 0.59 and a debt-to-equity ratio of 0.48. The firm has a market cap of $72,220.00, a price-to-earnings ratio of 20.14, a P/E/G ratio of 1.30 and a beta of 1.22. Walgreens Boots Alliance Inc has a 1-year low of $63.82 and a 1-year high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.27 by $0.01. The business had revenue of $30.74 billion for the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The business’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.10 EPS. research analysts forecast that Walgreens Boots Alliance Inc will post 5.59 earnings per share for the current fiscal year.

Walgreens Boots Alliance declared that its Board of Directors has approved a share repurchase program on Wednesday, October 25th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to buy shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th were issued a $0.40 dividend. The ex-dividend date of this dividend was Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a yield of 2.19%. Walgreens Boots Alliance’s dividend payout ratio is currently 44.20%.

Several analysts have recently issued reports on WBA shares. Needham & Company LLC reissued a “buy” rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a research note on Sunday, September 10th. BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. Royal Bank of Canada started coverage on shares of Walgreens Boots Alliance in a research note on Tuesday, September 19th. They set an “outperform” rating and a $96.00 price objective for the company. Jefferies Group reissued a “buy” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a research note on Wednesday, September 20th. Finally, Raymond James Financial reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Wednesday, September 27th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $86.05.

WARNING: This piece was posted by Watch List News and is the property of of Watch List News. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this piece can be accessed at https://www.watchlistnews.com/sompo-japan-nipponkoa-asset-management-co-ltd-takes-8-79-million-position-in-walgreens-boots-alliance-inc-wba/1798336.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with Analyst Ratings Network's FREE daily email newsletter.